[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.153.63. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1987

Comments on Continued Clinical Research on Systemic Aminocaproic Acid for Traumatic Hyphema-Reply

Author Affiliations

Pittsburgh

Arch Ophthalmol. 1987;105(5):612. doi:10.1001/archopht.1987.01060050029011
Abstract

In Reply.  —In light of Dr Romano's1 comments following the publication of the study by McGetrick et al, we were not surprised to hear from him concerning our study published in the February 1987 Archives. We believe that his letter makes several important points but, in general, misses its target.First, we thank Dr Romano for complimenting our work by calling it an excellent study. Along with the work by Crouch and Frenkel and McGetrick et al, it provides strong clinical support for the use of aminocaproic acid following traumatic hyphema, as espoused in an editorial by Dr Goldberg.2Dr Romano is concerned about continued clinical research on the use of aminocaproic acid. However, he has failed to grasp our reasons for conducting this study. Even after publication of the work by McGetrick et al, most of the private practitioners at our institution preferred not to use this

First Page Preview View Large
First page PDF preview
First page PDF preview
×